Category

Clinical Trials

Oncolytic adenovirus

TILT Biotherapeutics submits IND application

June 15, 2021

TILT Biotherapeutics has submitted an …

First patient enrolled in Oasmia trial

June 11, 2021

Oasmia Pharmaceutical has announced that …

David Fredrickson

New results from AstraZeneca’s OlympiA trial

June 7, 2021

Results from the Phase III …

Klaas Bakker

Oncopeptides announces results from the OCEAN study

June 6, 2021

Oncopeptides have announced positive results …

Nordic Nanovector

Preliminary results from Nordic Nanovector’s Archer-1 trial

May 25, 2021

Nordic Nanovector announces initial promising …

cantargia-goran

Cantargia announces positive trial results

May 25, 2021

The company has reported positive …

New promising findings about Ultimovacs’ cancer vaccine

May 24, 2021

Ultimovacs has announced that its …

Nanoform

Nanoform announces new clinical results

May 21, 2021

Nanoform has announced the completion …

Martin Holst Lange

Novo Nordisk presents results from its RESCUE trial

May 18, 2021

Novo Nordisk has presented results …

Tara Heitner

Cyxone initiates feasibility preclinical studies

May 10, 2021

The company has announced the …

Øystein Rekdal

Lytix Biopharma announces positive data

May 10, 2021

Lytix Biopharma has announced promising …

Oncolytic adenovirus

First patient dosed in TILT Biotherapeutics’ Phase I trial

May 5, 2021

The company has progressed to …

Ravi Rao

First patient dosed in Sobi’s XTEND-Kids study

May 4, 2021

Swedish Orphan Biovitrum has announced …

Martin Holst Lange

Novo Nordisk initiates phase 3a development with oral semaglutide

May 4, 2021

Novo Nordisk has announced the …

Francois Martelet

Green light for Oasmia’s phase 1b Docetaxel Micellar trial

April 26, 2021

Oasmia Pharmaceutical has announced that …

Mount Sinai

RhoVac adds prestigious hospital to its Phase IIb trial

April 23, 2021

RhoVac has announced that Mount …

1
2
3
4
5
···
37